Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
CO-PRESENTED BY
LIVE TV DownloadNews18 App
News18 English
»
1-min read

Aurobindo Pharma Shares Tank 7% After USFDA Action

Aurobindo Pharma added it is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

Trending Desk

Updated:May 17, 2019, 11:39 AM IST
facebookTwittergoogleskypewhatsapp
Aurobindo Pharma Shares Tank 7% After USFDA Action
Image for representation only.
Aurobindo Pharma shares tanked nearly 7% in early trade on Friday after the US Food and Drug Administration (USFDA) classified its inspection of the company’s API intermediates facilities of Unit I, IX and XI as Official Action Indicated (OAI).

OAI means a USFDA inspection revealed significant objectionable conditions or practices and action must be taken to address the issues. It also indicates that approvals of pending applications or supplements from the site maybe withheld.

“The company has received letters from the USFDA classifying the inspections concluded at our API (active pharmaceutical ingredients) facilities of Unit I and XI and intermediates facility of unit IX in February 2019 as Official Action Indicated.” the regulatory fiing said.

The company has already submitted its initial response to USFDA, Aurobindo Pharma said in the release.

The company is sending further updates on the committed corrective actions.

Aurobindo Pharma added it is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

Shares of Aurobindo Pharma were trading at Rs 678.35, down 6.6%, at 10:47am on BSE.
Read full article
Next Story
Next Story

Also Watch

facebookTwittergoogleskypewhatsapp
 
 
Most Active
Company Price Change %Gain
Reliance 1,339.80 1.05
Indiabulls Hsg 807.75 -0.83
HDFC 2,114.50 -0.38
SBI 337.55 -2.07
Tata Motors 176.80 -7.02
Company Price Change %Gain
Reliance 1,339.75 1.08
SBI 337.55 -2.05
HDFC Bank 2,403.80 -1.20
Indiabulls Hsg 808.25 -0.35
Tata Motors 176.60 -7.05
Top Gainers
Company Price Change %Gain
Dr Reddys Labs 2,667.00 3.00
Bharti Infratel 276.10 2.43
Britannia 2,848.70 1.70
Reliance 1,339.80 1.05
Titan Company 1,244.40 1.04
Company Price Change %Gain
Reliance 1,339.75 1.08
Bajaj Finance 3,432.65 0.76
HUL 1,783.50 0.62
Top Losers
Company Price Change %Gain
Tata Motors 176.80 -7.02
BPCL 374.45 -4.43
Zee Entertain 347.70 -4.08
IndusInd Bank 1,447.75 -3.14
Adani Ports 387.60 -3.12
Company Price Change %Gain
Tata Motors 176.60 -7.05
Maruti Suzuki 6,857.80 -3.25
IndusInd Bank 1,447.55 -3.02
Bharti Airtel 330.80 -2.66
M&M 638.80 -2.36

Live TV

Countdown To Elections Results
  • 01 d
  • 12 h
  • 38 m
  • 09 s
To Assembly Elections 2018 Results